Peptides · graded A to D · EU status, dated
Everyone's on peptides. Here's which ones have earned it.
Every peptide I'll talk about, graded A to D on the human evidence, with its EU status in plain words. What you'll never find on this page: a dose, a route, a source or a link. Those belong in your protocol, built on your bloodwork, or nowhere.
No baseline, no protocol.
A to D. Said out loud. Even about my favourites.
- A
Approved medicine, or several large human trials. Strong evidence for that claim, in that group of people.
- B
Small or short human studies. A real signal in people. Larger trials needed.
- C
Animal studies only. Not shown in humans.
- D
Lab data or anecdotes. No reliable evidence. Anecdotes and vibes.
A grade belongs to one claim in one group of people. A peptide can be an A for a rare disease and a C for the reason you want it. A grade is about the evidence, not about whether I like it, and it is never permission.
The list. Graded, dated, no doses.
Filter by the grade for the main use people buy each one for. Each row shows every claim the evidence grades separately.
Showing 19 of 19 peptides
TirzepatideMounjaro
Weight lossStudied forWeight and blood sugar in adults with obesity or type 2 diabetes.
Evidence grade, per claim- AWeight and HbA1c in obesity and type 2 diabetes. Nothing for lean or athletic use.
EU statusEU-authorised prescription medicine.Card 26 Sep 2026 · main use ASemaglutide
Weight lossStudied forWeight, type 2 diabetes, heart and kidney outcomes.
Evidence grade, per claim- AWeight, type 2 diabetes, heart and kidney outcomes.
EU statusEU-authorised prescription medicine.Card 26 Sep 2026 · main use ARetatrutideLY3437943
Weight lossStudied forWeight and blood sugar in obesity and type 2 diabetes.
Evidence grade, per claim- AWeight and HbA1c in obesity and type 2 diabetes.
- BLiver fat and body composition.
EU statusNot authorised in the EU. Investigational.Card 26 Sep 2026 · main use ATesamorelin
Weight lossStudied forBelly fat in one patient group.
Evidence grade, per claim- AVisceral fat in HIV lipodystrophy only.
- CAthletic use.
EU statusNot authorised in the EU. The application was withdrawn.Card 26 Sep 2026 · main use ASelankTP-7
Drive and focusStudied forAnxiety in patients, in small trials.
Evidence grade, per claim- BAnxiety in patients. Small, unreplicated.
- CCognition in healthy adults.
- DSleep.
EU statusNot authorised in the EU. Registered in Russia.Card 26 Sep 2026 · main use BSemax
Drive and focusStudied forNeurological patients, and brain imaging in healthy volunteers.
Evidence grade, per claim- BNeurological patients, roughly. Registered in Russia.
- CCognition in healthy adults.
EU statusStatus being confirmed.Card 26 Sep 2026 · main use CKisspeptin-10
Drive and focusStudied forThe hormone signal behind testosterone, and libido.
Evidence grade, per claim- BLH and testosterone rise.
- CLibido.
EU statusStatus being confirmed.Card 26 Sep 2026 · main use CCJC-1295DAC and no-DAC forms
PhysiqueStudied forGrowth hormone and IGF-1 levels.
Evidence grade, per claim- BShort-term GH and IGF-1 rise, DAC form only. The no-DAC form has no human study.
- CMuscle and sleep.
EU statusNot approved anywhere.Card 26 Sep 2026 · main use CIpamorelin
PhysiqueStudied forShort-term growth hormone release.
Evidence grade, per claim- BAcute GH release, small human studies.
- CMuscle, bone, recovery.
- DSleep.
EU statusNot approved anywhere.Card 26 Sep 2026 · main use CGHK-Cucopper peptide
Repair and healthStudied forSkin and wound endpoints, applied to the skin.
Evidence grade, per claim- BSome topical wound and cosmetic endpoints.
- CInjected use: recovery, hair, longevity.
EU statusA cosmetic ingredient when applied to skin and notified. Injected, it counts as a medicine by presentation.Card 26 Sep 2026 · main use CBPC-157
Repair and healthStudied forTendon, gut and recovery, mostly in animals.
Evidence grade, per claim- CTendon, muscle, recovery and gut. The weight of evidence is animal.
EU statusNot authorised in the EU.Card 26 Sep 2026 · main use CTB-500thymosin beta-4 fragment
Repair and healthStudied forTissue repair in animal models.
Evidence grade, per claim- CRepair. No human trial of the fragment itself.
EU statusNot authorised in the EU.Card 26 Sep 2026 · main use CKPV
Repair and healthStudied forGut inflammation in animals.
Evidence grade, per claim- CGut inflammation. Animal and cell data only.
EU statusNot authorised in the EU.Card 26 Sep 2026 · main use CThymosin alpha-1thymalfasin
Repair and healthStudied forImmune response in hepatitis B and sepsis trials.
Evidence grade, per claim- AHuman trials exist in hepatitis B and sepsis. Mixed; the largest sepsis trial was negative.
- CImmune support in healthy adults.
EU statusNo EMA authorisation found.Card 26 Sep 2026 · main use CSS-31elamipretide
Biohacking performanceStudied forMuscle strength in one rare disease.
Evidence grade, per claim- ABarth syndrome muscle strength only. US approval, 2025.
- CLongevity and recovery in healthy adults.
EU statusNo EMA authorisation found. To verify.Card 26 Sep 2026 · main use CMOTS-c
Biohacking performanceStudied forFat loss and ageing in mice.
Evidence grade, per claim- CFat loss and longevity.
EU statusStatus being confirmed.Card 26 Sep 2026 · main use CEpitalonEpithalon
Biohacking performanceStudied forLongevity and sleep, animals plus one small human study.
Evidence grade, per claim- CLongevity and sleep.
- DCell-culture telomere findings.
EU statusStatus being confirmed.Card 26 Sep 2026 · main use CPinealon
Biohacking performanceStudied forCognition and ageing.
Evidence grade, per claim- CNeuroprotection in animals and cells.
- DHuman cognition and longevity.
EU statusNot authorised in the EU.Card 26 Sep 2026 · main use DSLU-PP-332not a peptide
Biohacking performanceStudied forExercise-like effects in mice.
Evidence grade, per claim- DEvery human claim. C in mice.
EU statusStatus being confirmed.Card 26 Sep 2026 · main use D
Graded for main use:4 at A1 at B12 at C2 at D
Grades and status are copied from the P&P compound cards (built 26 Sep 2026), never re-graded by hand. Status is plain language, not legal advice, and rules change. Two of the A grades are prescription medicines you get from a doctor.
How I run a protocol. Same order, every time.
- 01
Application. Ten quick questions. No health data until you've agreed to how we handle it.
- 02
Strategy Meeting with Bobby. Where you are, where you want to be, and whether peptide coaching is the right way there. If it isn't, I'll tell you.
- 03
Screening. Who this isn't for is below. Some people get coached on the basics and start no compound until their own doctor clears it.
- 04
Baseline bloods at home. Morning, fasted, the full panel.
- 05
The grade conversation. What the evidence says, and what it doesn't.
- 06
One change. One variable, so the retest can tell you something.
- 07
Weekly check-ins and voice notes. Adjusted every week, in writing.
- 08
Retest at 8 to 12 weeks. Same lab, same conditions.
- 09
Continue, change or stop. Your call at every step. My job is that you make it with the evidence and your own numbers in front of you.
Test. Change one thing. Retest.
What I never do.
- ×Never a dose, route or schedule on a public page, in a DM or on a sales call. Doses live only inside a client’s protocol, as guideline ranges with their source, set against their bloodwork.
- ×Never sell, supply or source a compound. No supplier or affiliate links.
- ×Never start a protocol without a baseline.
- ×Never start anything new while a result is flagged. A doctor sees it first.
- ×Never coach compounds for anyone under 25, pregnant, trying to conceive or breastfeeding. Athletes in a tested sport get general coaching only: most compounds in this field are prohibited in sport.
- ×Never call a compound safe or proven, and never promise a result or an outcome free of risk.
Some of these compounds are prescription medicines, some are sold for research and aren't approved for human use, and the rules differ by country. A grade tells you what the evidence says. It is not permission.
What I ran, what it did, what it cost.
I've run peptides on myself after a skiing accident in Austria and a motorbike crash, and I've made the mistakes everybody else is making right now. The SARMs chapter is in there too, told as what it cost me. The full story and my lab reports are on the about page.
Straight answers about the list.
Why are there no doses on this page?
Because a dose without your bloodwork, your history and a retest is a guess. Doses live only inside a client's protocol, as guideline ranges with their source, set against their own numbers. Never on a public page, in a DM or on a sales call.
Does a grade A mean it's safe?
No. A grade says how much human evidence there is for one claim in one group of people. It says nothing about whether a compound suits you, and it is not permission. Two of the A grades are prescription medicines you get from a doctor.
Do you sell peptides?
No. I coach you on peptides. I don't sell them. No compounds, no sourcing, no supplier or affiliate links, no discount codes.
Is this legal?
Coaching and education are. The compounds are a different question: some are prescription medicines, some are sold for research and aren't approved for human use, and the rules differ by country. The status column above is plain language, not legal advice.